1McDonald DG,Najan Y;Keegan MB,et al.The use of lamotrigine,vigabatrin and gabap-entin as add-on therapy in intractable epilepsy of childhood.Seizure,2005,14(2):112-116.
3Armijo JA, Shushtarian M, Valdizan EM, et al. Ion channels and epilepsy[J ]. Curr Pharm Des, 2005,11 (15): 1975 - 2003.
4Remy S, Urban BW, Elger CE, et al. Anticonvulsant pharmacology of volatge - gated Na+ channels in hippocampal neurons of control and chronically epileptic rats [ J ]. Eur J Neurosci, 2003, 17 ( 2 ):2684 - 2658.
5Spadoni F, Hainsworth AH, Mercuri NB, et al. Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons[J]. Neuroreport,2002,13(9):1167 - 1170.
6Brodie MJ. Lamotrigine[J ]. Lancet, 1992,339(8806): 1397 - 1400.
7Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues[J ]. Epilepsia, 2003,44: 21 - 29.
8McDonald DG, Najan Y, Keegan MB, et al. The use of lamotrigine,vigabatrin and gabapentin as add - on therapy in intractable epilepsy of childhood[ J ]. Seizure, 2005,14 (2): 112 - 116.
9Vigneswari G, Sofiah A, Hussain IH. Lamotrigine as an add-on therapy in intractable paediatric epilepsy - the kuala lumpur hospital experience[J ]. Med J Malaysia, 2001,56 (3): 359 - 364.
10Schubert R. Attention deficit disorder and epilepay[J ]. Pediatr Neurol,2005,32(1): 1 - 10.
5Mark S, David R, Cairns P, a al . Validation of a new quality of life measure for children with epilepsy[J]. Epilepsia ,2000, 41(61) :765-7741.
6Perucca E. An introduction to antiepileptic drugs[J]. Epilepsia , 2005,46(14) :312-371.
7Hirose G. An overview of epilepsy: its history, classification, pathophysiology and management[J]. Brain Nerve, 2013,65 (5) :509-520.
8Peake D, Mordekar S, Gosalakkal J, et al. Retention rate of Levetiracetam in children with intractable epilepsy at 1 year [J]. Seizure, 2007, 4(16) : 185-189.
9Lehtimaki KA, Keramen T,Palmnio J, et al . Increased plasma levels of cytokines after seizures in localization-related epilepsy [J]. Acta Neurol Scand, 2007,116 (4):226-230.
